Frontal lobe volume in patients with Huntington's disease

Neuropathologic and neuroimaging studies have suggested that frontal lobes are affected in Huntington's disease (HD), and that atrophy in this region may be associated with some of the cognitive impairment and clinical decline observed in patients with HD. We measured gray and white matter volumes within the frontal lobes on MRI for 20 patients with HD (10 mildly affected and 10 moderately affected) and 20 age- and sex-matched control subjects. We also correlated frontal lobe measurements with measures of symptom severity and cognitive function. Patients who were mildly affected had frontal lobe volumes (both gray and white matter) essentially identical to those of control subjects, despite clearly abnormal basal ganglia. Patients who were moderately affected demonstrated significant reductions in total frontal lobe volume (17%) and frontal white matter volume (28%). Frontal lobe white matter volume reductions, but not total frontal lobe volume reductions, were disproportionately greater than overall brain volume reductions (17%). Frontal lobe volume correlated with symptom severity and general cognitive function, but these correlations did not remain significant after taking into account total brain volume. We conclude that cognitive impairment and symptom severity are associated with frontal lobe atrophy, but this association is not specific to the frontal lobes. Frontal lobe atrophy (like total brain atrophy) occurs in later stages of increasing HD symptom severity and this atrophy primarily involves white matter.

[1]  R. Royall,et al.  Improving sterological estimates for the volume of structures identified in three-dimensional arrays of spatial data , 1997, Journal of Neuroscience Methods.

[2]  Godfrey D. Pearlson,et al.  Measurement of frontal lobe volume on magnetic resonance imaging scans , 1997, Psychiatry Research: Neuroimaging.

[3]  M. Kasuga,et al.  Development of flexible ventriculoscope (Yamadori-type VII) and its application to experimental animals , 1997, Journal of Neuroscience Methods.

[4]  G. Pearlson,et al.  Longitudinal change in basal ganglia volume in patients with Huntington's disease , 1997, Neurology.

[5]  G. Pearlson,et al.  Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. , 1996, Archives of neurology.

[6]  S. W. Davies,et al.  Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.

[7]  G D Pearlson,et al.  Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease. , 1996, Archives of neurology.

[8]  J. Brandt,et al.  Trinucleotide repeat length and clinical progression in Huntington's disease , 1996, Neurology.

[9]  J. Brandt,et al.  Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at‐risk persons , 1994, Neurology.

[10]  C A Ross,et al.  Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. , 1993, Human molecular genetics.

[11]  J. Fuster Frontal lobes , 1993, Current Opinion in Neurobiology.

[12]  R. Wilson,et al.  Neuropsychology of Alzheimer's disease and other dementias , 1993 .

[13]  S. Folstein,et al.  Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease , 1992, Annals of neurology.

[14]  Persha Aj Early identification and prevention of mental retardation. , 1992 .

[15]  Christopher A. Ross,et al.  Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease , 1991, Neuroscience Letters.

[16]  Terry L. Jernigan,et al.  Cerebral structure on MRI, part II: Specific changes in Alzheimer's and Huntington's diseases , 1991, Biological Psychiatry.

[17]  J. Kurtzke,et al.  CT brainstem abnormalities in the differential diagnosis of Huntington's disease. , 1990, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[18]  G D Pearlson,et al.  Brain atrophy in Huntington's disease. A CT-scan study. , 1989, Neuroradiology.

[19]  S. Folstein,et al.  Neuropsychological and neuroradiological correlates in Huntington's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[20]  J. Vonsattel,et al.  Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease , 1988, Journal of neuropathology and experimental neurology.

[21]  R. Hichwa,et al.  Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function , 1988, Annals of neurology.

[22]  M. Mendez,et al.  Cortical auditory disorders: clinical and psychoacoustic features. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[23]  N. Reynolds The diagnosis of Huntington's disease , 1987, Neurology.

[24]  R. L. Rogers,et al.  Decreased cerebral blood flow precedes multi‐infarct dementia, but follows senile dementia of Alzheimer type , 1986, Neurology.

[25]  R. Ferrante,et al.  Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.

[26]  S. Folstein,et al.  Clinical correlates of dementia and disability in Huntington's disease. , 1984, Journal of clinical neuropsychology.

[27]  R. D. Hunt,et al.  Huntington's dementia. Clinical and neuropsychological features. , 1978, Archives of general psychiatry.

[28]  R. Dom,et al.  Neuropathology of Huntington's chorea , 1976, Neurology.